{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T15:33:10Z","timestamp":1792251190865,"version":"4.4.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K16630"],"award-info":[{"award-number":["22K16630"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.thromres.2025.109408","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T23:36:25Z","timestamp":1753313785000},"page":"109408","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The modified Japanese Association for Acute Medicine disseminated intravascular coagulation diagnostic criteria in sepsis is useful for an indicator of initiating treatment for disseminated intravascular coagulation"],"prefix":"10.1016","volume":"253","author":[{"given":"Tadashi","family":"Matsuoka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuma","family":"Yamakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Umemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noritaka","family":"Ushio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Hisamune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohji","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Honmma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.thromres.2025.109408_bb0005","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1208623","article-title":"Severe sepsis and septic shock","volume":"369","author":"Angus","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.thromres.2025.109408_bb0010","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1055\/s-0033-1343894","article-title":"Sepsis and thrombosis","volume":"39","author":"Levi","year":"2013","journal-title":"Semin. Thromb. Hemost."},{"issue":"4","key":"10.1016\/j.thromres.2025.109408_bb0015","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2141.2005.05753.x","article-title":"The interactions between inflammation and coagulation","volume":"131","author":"Esmon","year":"2005","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.thromres.2025.109408_bb0020","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jiac.2013.07.006","article-title":"Epidemiology of severe sepsis in Japanese intensive care units: a prospective multicenter study","volume":"20","author":"Ogura","year":"2014","journal-title":"J. Infect. Chemother."},{"issue":"3","key":"10.1016\/j.thromres.2025.109408_bb0025","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/01.CCM.0000202209.42491.38","article-title":"A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria","volume":"34","author":"Gando","year":"2006","journal-title":"Crit. Care Med."},{"issue":"9","key":"10.1016\/j.thromres.2025.109408_bb0030","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-017046","article-title":"New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey","volume":"7","author":"Iba","year":"2017","journal-title":"BMJ Open"},{"issue":"11","key":"10.1016\/j.thromres.2025.109408_bb0035","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1055\/s-0044-1786808","article-title":"Proposal and validation of a clinically relevant modification of the Japanese Association for Acute Medicine Disseminated Intravascular Coagulation Diagnostic Criteria for Sepsis","volume":"124","author":"Yamakawa","year":"2024","journal-title":"Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2025.109408_bb0040","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1055\/s-0038-1676610","article-title":"External validation of the two newly proposed criteria for assessing coagulopathy in sepsis","volume":"119","author":"Yamakawa","year":"2019","journal-title":"Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.thromres.2025.109408_bb0045","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1055\/s-0039-1693740","article-title":"Identifying Sepsis Populations Benefitting from Anticoagulant Therapy: A Prospective Cohort Study Incorporating a Restricted Cubic Spline Regression Model","volume":"119","author":"Yamakawa","year":"2019","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2025.109408_bb0050","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s13054-016-1415-1","article-title":"Benefit profile of anticoagulant therapy in sepsis: a nationwide multicentre registry in Japan","volume":"20","author":"Yamakawa","year":"2016","journal-title":"Crit. Care"},{"issue":"5","key":"10.1016\/j.thromres.2025.109408_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102519","article-title":"A machine learning model for early and accurate prediction of overt disseminated intravascular coagulation before its progression to an overt stage","volume":"8","author":"Umemura","year":"2024","journal-title":"Res. Pract. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2025.109408_bb0060","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jama.290.2.238","article-title":"Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial","volume":"290","author":"Abraham","year":"2003","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.thromres.2025.109408_bb0065","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1097\/00003246-200111000-00007","article-title":"Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo-controlled, single-blind, dose escalation study","volume":"29","author":"Abraham","year":"2001","journal-title":"Crit. Care Med."},{"issue":"5","key":"10.1016\/j.thromres.2025.109408_bb0070","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/BF02982120","article-title":"A comparative double-blind randomized trial of activated protein C and unfractionated heparin in the treatment of disseminated intravascular coagulation","volume":"75","author":"Aoki","year":"2002","journal-title":"Int. J. Hematol."},{"issue":"4","key":"10.1016\/j.thromres.2025.109408_bb0075","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s001340050576","article-title":"Antithrombin III (ATIII) replacement therapy in patients with sepsis and\/or postsurgical complications: a controlled double-blind, randomized, multicenter study","volume":"24","author":"Baudo","year":"1998","journal-title":"Intensive Care Med."},{"issue":"11","key":"10.1016\/j.thromres.2025.109408_bb0080","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1111\/j.1538-7836.2004.00955.x","article-title":"Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation","volume":"2","author":"Dhainaut","year":"2004","journal-title":"J. Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.thromres.2025.109408_bb0085","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s001340050642","article-title":"Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis","volume":"24","author":"Eisele","year":"1998","journal-title":"Intensive Care Med."},{"issue":"3","key":"10.1016\/j.thromres.2025.109408_bb0090","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1378\/chest.104.3.882","article-title":"Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation","volume":"104","author":"Fourrier","year":"1993","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.thromres.2025.109408_bb0095","doi-asserted-by":"crossref","DOI":"10.1186\/cc13163","article-title":"A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis","volume":"17","author":"Gando","year":"2013","journal-title":"Crit. Care"},{"issue":"12","key":"10.1016\/j.thromres.2025.109408_bb0100","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012850","article-title":"Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial","volume":"6","author":"Hagiwara","year":"2016","journal-title":"BMJ Open"},{"issue":"9","key":"10.1016\/j.thromres.2025.109408_bb0105","first-page":"678","article-title":"Efficacy of gabexate mesilate on disseminated intravascular coagulation as a complication of infection developing after abdominal surgery","volume":"103","author":"Hsu","year":"2004","journal-title":"J. Formos. Med. Assoc."},{"issue":"4","key":"10.1016\/j.thromres.2025.109408_bb0110","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/CCM.0b013e31819c06bc","article-title":"Unfractioned heparin for treatment of sepsis: A randomized clinical trial (The HETRASE Study)","volume":"37","author":"Jaimes","year":"2009","journal-title":"Crit. Care Med."},{"issue":"1","key":"10.1016\/j.thromres.2025.109408_bb0115","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1538-7836.2005.01697.x","article-title":"Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation","volume":"4","author":"Kienast","year":"2006","journal-title":"J. Thromb. Haemost."},{"issue":"10","key":"10.1016\/j.thromres.2025.109408_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8101553","article-title":"Human soluble recombinant thrombomodulin, ART-123, resolved early phase coagulopathies, but did not significantly Alter the 28 day outcome in the treatment of DIC associated with infectious systemic inflammatory response syndromes","volume":"8","author":"Mori","year":"2019","journal-title":"J. Clin. Med."},{"issue":"7","key":"10.1016\/j.thromres.2025.109408_bb0125","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.ajem.2011.06.003","article-title":"Effects of antithrombin and gabexate mesilate on disseminated intravascular coagulation: a preliminary study","volume":"30","author":"Nishiyama","year":"2012","journal-title":"Am. J. Emerg. Med."},{"issue":"5","key":"10.1016\/j.thromres.2025.109408_bb0130","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1097\/00003246-200005000-00027","article-title":"Is protease inhibitor a choice for the treatment of pre- or mild disseminated intravascular coagulation?","volume":"28","author":"Nishiyama","year":"2000","journal-title":"Crit. Care Med."},{"issue":"11","key":"10.1016\/j.thromres.2025.109408_bb0135","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1007\/s00134-016-4405-5","article-title":"Protein C zymogen in severe sepsis: a double-blinded, placebo-controlled, randomized study","volume":"42","author":"Pappalardo","year":"2016","journal-title":"Intensive Care Med."},{"issue":"1","key":"10.1016\/j.thromres.2025.109408_bb0140","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1538-7836.2006.02267.x","article-title":"Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial","volume":"5","author":"Saito","year":"2007","journal-title":"J. Thromb. Haemost."},{"issue":"9","key":"10.1016\/j.thromres.2025.109408_bb0145","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1097\/CCM.0b013e31828e9b03","article-title":"A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation","volume":"41","author":"Vincent","year":"2013","journal-title":"Crit. Care Med."},{"issue":"8","key":"10.1016\/j.thromres.2025.109408_bb0150","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"issue":"10219","key":"10.1016\/j.thromres.2025.109408_bb0155","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.thromres.2025.109408_bb0160","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chronic Dis."},{"issue":"11","key":"10.1016\/j.thromres.2025.109408_bb0165","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med. Care"},{"issue":"1","key":"10.1016\/j.thromres.2025.109408_bb0170","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1515\/em-2013-0005","article-title":"A tutorial on interaction","volume":"3","author":"VanderWeele","year":"2014","journal-title":"Epidemiol. Methods"},{"issue":"8","key":"10.1016\/j.thromres.2025.109408_bb0175","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13145","article-title":"Understanding of interaction (subgroup) analysis in clinical trials","volume":"49","author":"Brankovic","year":"2019","journal-title":"Eur. J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.thromres.2025.109408_bb0180","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/jth.13230","article-title":"Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials","volume":"14","author":"Umemura","year":"2016","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2025.109408_bb0185","doi-asserted-by":"crossref","DOI":"10.1186\/cc12783","article-title":"A multicenter, prospective validation study of the Japanese Association for Acute Medicine disseminated intravascular coagulation scoring system in patients with severe sepsis","volume":"17","author":"Gando","year":"2013","journal-title":"Crit. Care"},{"issue":"6","key":"10.1016\/j.thromres.2025.109408_bb0190","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1160\/TH15-12-0987","article-title":"Recombinant human soluble thrombomodulin and mortality in sepsis-induced disseminated intravascular coagulation. A multicentre retrospective study","volume":"115","author":"Hayakawa","year":"2016","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2025.109408_bb0195","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s13054-018-2186-7","article-title":"Characteristics, management, and in-hospital mortality among patients with severe sepsis in intensive care units in Japan: the FORECAST study","volume":"22","author":"Abe","year":"2018","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.thromres.2025.109408_bb0200","first-page":"399","article-title":"Persistent and late-onset disseminated intravascular coagulation are closely related to poor prognosis in patients with sepsis","volume":"124","author":"Matsuoka","year":"2023","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2025.109408_bb0205","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s13054-019-2587-2","article-title":"Recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy (SCARLET): an updated meta-analysis","volume":"23","author":"Yamakawa","year":"2019","journal-title":"Crit. Care"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825001586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825001586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T09:20:59Z","timestamp":1778664059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384825001586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":41,"alternative-id":["S0049384825001586"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109408","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The modified Japanese Association for Acute Medicine disseminated intravascular coagulation diagnostic criteria in sepsis is useful for an indicator of initiating treatment for disseminated intravascular coagulation","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109408","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109408"}}